The value of tuberculosis elimination and of progress in tuberculosis control in twentieth-century England and Wales [Review article]
METHODS: An original methodology that utilises original data is used, which facilitates the calculation of the number of life years that have been saved as a result of the decline in the TB mortality rate, prevalence rate and quality of life burden.
RESULTS: The magnitude of the decline in the mortality and morbidity burden of TB is estimated at 104 425 life years, which is valued to be worth in excess of US$127 billion. The value of improvements in morbidity contributes nearly as much as the more obvious gains for mortality.
CONCLUSION: Such significant results indicating the value of improvements in TB control have important implications for our understanding of these achievements and justify increased spending in developing countries that continue to be plagued by high rates of TB prevalence.
Document Type: Review Article
Affiliations: University of Cambridge, Cambridge, UK
Publication date: September 1, 2009
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content